EBS · Emergent BioSolutions Inc. · Investor Relations
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Recent news
| Date | Headline |
|---|---|
| 2026-09-15 |
Media Advisory: Emergent to Host Ribbon Cutting Ceremony at Canton Manufacturing Facility
Company leaders, elected officials and community stakeholders will come together on September 16, 2026 to mark milestone in advanced biopharmaceutical manufacturing CANTON, Mass., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a ribbon cutting ceremony on |
| 2026-09-03 |
Emergent BioSolutions Completes Repurchase of $75 Million Aggregate Principal Amount of Senior Unsecured Notes
Repurchase reduces unsecured note balance to approximately $364.7 million Management to discuss this key milestone and broader transformation progress at upcoming investor conferences GAITHERSBURG, Md., Sept. 03, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. |
| 2026-09-01 |
Emergent BioSolutions Awarded Contract Modification Valued at Approximately $24 Million for CYFENDUS® (Anthrax Vaccine Adsorbed, Adjuvanted)
GAITHERSBURG, Md., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced a contract modification valued at approximately $24 million from the Biomedical Advanced Research and Development Authority (BARDA), part of the Administration for Strategic Preparedness and |
| 2026-08-31 |
Emergent BioSolutions Awarded Government of Canada Standing Offer for NARCAN® Nasal Spray
Standing offer expands access to opioid overdose emergency treatment across participating federal, provincial and territorial organizations in Canada WINNIPEG, Manitoba, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has been awarded a standing |
| 2026-08-31 |
Emergent BioSolutions Reinforces Commitment to Opioid Overdose Education and Preparedness on International Overdose Awareness Day
Ready to Rescue campaign returns to U.S. college campuses with Release Recovery Founder and CEO Zac Clark Partnership with professional baseball player Davis Schneider seeks to raise awareness of opioid poisoning preparedness across Canada GAITHERSBURG, Md., Aug. |
| 2026-08-05 |
Emergent BioSolutions Commits to Cross-Sector Collaboration Against Biological Threats in an Evolving Global Security Environment
GAITHERSBURG, Md., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS), a global biodefense company, today highlighted the increasing importance of biological threat preparedness as allied nations confront an evolving security environment characterized by geopolitical conflict, |
| 2026-08-05 |
Emergent BioSolutions Reports Second Quarter 2026 Financial Results
Second Quarter 2026 Total Revenues of $234.3 million, an improvement of 66% versus prior year Second Quarter 2026 Net Loss of $180.2 million worsening 1,402% versus prior year, largely due to a $191.3 million non-cash impairment charge Second Quarter 2026 Adjusted Net Income of $30.9 million |
| 2026-07-22 |
Emergent BioSolutions to Report Second Quarter 2026 Financial Results on August 5, 2026
GAITHERSBURG, Md., July 22, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Wednesday, August 5, 2026, at 5:00 p.m. eastern time to discuss the financial results for the second quarter of 2026. Participants can access the conference call live via |
| 2026-06-29 |
Emergent BioSolutions Secures Contract Modification Valued at Approximately $52.7 Million for ACAM2000® (Smallpox and Mpox (Vaccinia) Vaccine, Live) from the U.S. Government
GAITHERSBURG, Md., June 29, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE:EBS) today announced it has been awarded a contract modification valued at $52.7 million from the Administration for Strategic Preparedness and Response (ASPR) at the United States Department of Health and Human |
| 2026-06-04 |
Emergent BioSolutions Supports Victoria’s Voice Foundation’s National Naloxone Awareness Day to Help Save Lives from Opioid Overdose
Efforts focus on increasing awareness, expanding access to lifesaving NARCAN® Nasal Spray and reaching more communities with educational initiatives and resources GAITHERSBURG, Md., June 04, 2026 (GLOBE NEWSWIRE) -- In honor of National Naloxone Awareness Day on June 6 th, Emergent BioSolutions |
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-14 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-09-09 | 21st Annual Wells Fargo Healthcare Conference | Conference |
| 2026-08-05 | Q2 2026 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2026-04-30 | Q1 2026 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2026-02-26 | Q4 2025 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2026-01-15 | 44th Annual J.P. Morgan Healthcare Conference | Conference |
| 2025-10-29 | Q3 2025 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2025-08-06 | Q2 2025 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2025-05-07 | Q1 2025 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2025-04-30 | Emergent BioSolutions 2025 Virtual Annual Meeting of Stockholders | Shareholder meeting |
| 2025-03-03 | Q4 2024 Emergent BioSolutions Inc. Earnings Conference Call | Earnings call |
| 2025-01-15 | 43rd Annual J.P. Morgan Healthcare Conference | Conference |